The Classification of Lymphoid Leukaemias

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Lymphoproliferative disorders are increasingly classified using advanced immunological and molecular techniques.
• Peripheral blood morphology, bone marrow histology, and lymph node pathology aid objective classification.
• Understanding disease biology and natural history is crucial for predicting therapy response.

Purpose of the Study:

• To outline the objective classification of lymphoproliferative disorders.
• To differentiate between primary leukaemias and non-Hodgkin's lymphoma (NHL) in leukaemic phase.
• To highlight diagnostic challenges and classification of mature T-cell leukaemias.

Main Methods:

• Immunological and molecular techniques.
• Morphological and histopathological analysis of blood, bone marrow, and lymph nodes.
• Immunophenotyping, cytogenetic, and DNA analyses.

Main Results:

• Objective classification of lymphoproliferative disorders is now possible.
• Chronic B-cell disorders are categorized into primary leukaemias and NHL in leukaemic phase.
• Mature T-cell leukaemias are distinguished from B-cell disorders using immunological markers, cytogenetics, and DNA analysis.

Conclusions:

• Precise diagnosis and classification of lymphoproliferative disorders are enhanced by integrated techniques.
• Challenges remain in classifying heterogeneous low-grade NHL and chronic lymphocytic leukaemia with malignant transformation.
• Characterizing T-cell leukaemias requires morphology, histopathology, and epidemiological factors like HTLV-1.